Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia / 감염과화학요법
Infection and Chemotherapy
; : 267-273, 2016.
Article
in En
| WPRIM
| ID: wpr-179931
Responsible library:
WPRO
ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Vancomycin
/
Methicillin Resistance
/
Bacteremia
/
Methicillin-Resistant Staphylococcus aureus
Language:
En
Journal:
Infection and Chemotherapy
Year:
2016
Type:
Article